Global Animal Health Market Size study, by Animal Type (Production Animal, Companion Animal) by Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment & Disposables, Others) by Distribution Channel (Retail, E-Commerce, Veteri

Global Animal Health Market Size study, by Animal Type (Production Animal, Companion Animal) by Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment & Disposables, Others) by Distribution Channel (Retail, E-Commerce, Veterinary Hospitals & Clinics) by End use (Reference laboratories, Point-of-care Testing/In-house testing, Veterinary Hospitals & Clinics, Others) and Regional Forecasts 2022-2028

Global Animal Health Market is valued approximately USD 36.37 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.72 % over the forecast period 2022-2028 Animals require proper attention from their owners on a daily basis in order to maintain excellent health. Because the production of healthy livestock guarantees a stable food supply and maintains consumer price stability, frequent animal health monitoring and the prevention of animal disease outbreaks have become essential for every country. The animal health industry is steadily gaining pace around the world, since effective management and prevention are required to minimise the spread of zoonotic illnesses among animals and humans. A huge growth in global demand for protein food, as well as an increase in the frequency of zoonotic and food-borne diseases, are driving the industry. Companies have been spurred to develop enhanced vaccines and medications as a result of the enormous growth in disease prevalence. As a result of the increasing demand, there has been an increase in the number of companies making regular efforts to control pathogen contamination concerns and food-borne diseases, which is helping to drive market expansion. Furthermore, the total market is expected to be driven by the growing number of government programmes to promote animal health products. During the pandemic, the use of telemedicine has increased significantly. When it comes to purchasing veterinarian items and pet food, pet owners prefer online channels such as eCommerce. According to the United Nations Department of Economic and Social Affairs, the global population is currently around 7.3 billion people and is expected to reach around 9.7 billion by 2050; of these, according to the International Fund for Agricultural Development's estimates (IFAD), 795 million people are undernourished. The numbers above demonstrate the urgent need to increase food supply by adopting livestock on a wide basis.. The Innovative Medicines Initiative (IMI), for example, is a public-private collaboration that supports collaborative research to improve veterinary pharmaceutical innovation in Europe. However, high cost associated with animal healthcare drugs impedes the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Animal Health Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Because of the vast range of definite measures adopted by government animal welfare groups that are continually working for general improvement in animal health, North America accounted for the greatest market share. Furthermore, technological developments, an increase in the number of pet owners, and an increase in the frequency of zoonotic diseases are likely to drive market expansion in this country. Several large companies' coordinated efforts to improve their R&D skills and assure high-quality standards are expected to drive demand even higher in this region. Furthermore, the majority of the share can be linked to the region's high disease burden. From 2022 to 2028, the Asia Pacific regional market is expected to grow at the fastest rate. This region's rapid expansion is thought to be the result of constant R&D spending by major companies in the animal health industry, as well as their efforts to sell branded and generic treatments at a low cost. The exponential expansion is due to increased understanding of pet nutrition and supplies, as well as increased disposable cash.

Major market player included in this report are:
Zoetis
Ceva Santé Animale
Merck Animal Health
Vetiquinol S.A.
Boehringer Ingelheim GmbH
Bayer AG
Virbac
Heska
Nutreco N.V.
Dechra Pharmaceuticals
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Animal Type:
Production Animal
Companion Animal
By Product:
Vaccines
Pharmaceuticals
Medicinal Feed Additives
Diagnostics
Equipment & Disposables
Others
By Distribution Channel:
Retail
E-Commerce
Veterinary Hospitals & Clinics
By End use:
Reference laboratories
Point-of-care Testing/In-house testing
Veterinary Hospitals & Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Animal Health Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Zoetis
Ceva Santé Animale
Merck Animal Health
Vetiquinol S.A.
Boehringer Ingelheim GmbH
Bayer AG
Virbac
Heska
Nutreco N.V.
Dechra Pharmaceuticals

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.